Protective Effect of Low Dose Melatonin on Radiation-Induced Damage to Rat Liver

Published on Friday, 12 December 2025

Abstract

Background: Melatonin is a free radical scavenger. It has also antioxidant effects through its stimulatory actions on antioxidant system.

Objective: We conducted this study to examine the effect of different oral doses of melatonin on liver tissue.

Methods: We used 42 rats—6 rats in each group. Group I served as the control group; group II rats were pretreated with only melatonin; group III was exposed to radiation only; and groups IV to VII were pretreated with different doses of melato- nin (10, 100, 200, 400 µg/kg, respectively) and exposed to 6 Gy whole body gamma irradiation.

Results: Whole body irradiation induced liver tissue damage by increasing malondialdehyde (MDA) concentrations and decreasing glutathione (GSH) levels. Hepatic MDA levels in irradiated rats that were pretreated with oral administration of melatonin in Groups V, VI and VII, were signiicantly decreased, while the GSH levels were signiicantly increased.

Conclusion: Oral administration of melatonin may prevent radiation-induced liver damage. This radio-protective effect is dose-dependent.

Download the complete article

About this publication.

- The Di Bella Method (A Fixed Part - Melatonin tablets. From 30-40mg/day up to 200mg/day and more orally in patients with advanced stage of cancer disease and/or patients without respond to traditional treatments);

- Melatonin use in cancer patients have started in 1974, when melatonin prepared according to Prof. Di Bella’s formulation [...]. For 11 days was administered to the patient, admitted to the general medical ward at the Maggiore-Pizzardi Hospital in Bologna, very slowly (over approx. 8 hours) and intravenously administered 1000 mg of melatonin for 11 days. During the course of each day, the patient was intravenously administered 4 saline drips of 500 ml, each containing ten 25 mg bottles of freeze-dried melatonin, lasting 2 hours, totaling 1000 mg per day. No other drug of any kind was administered in order to ascertain the effect of the MLT without interference [...]. From Melatonin with adenosine solubilized in water and stabilized with glycine for oncological treatment - technical preparation, effectivity and clinical findings;

- About Melatonin - In vitro, review and in vivo publications;

- Publication: Melatonin anticancer effects: Review (from Di Bella's Foundation);

- Publication: Key aspects of melatonin physiology: 30 years of research (from Di Bella's Foundation);

- The Di Bella Method (A Variable Part - Omega 3 Essential/Unsaturated Fatty Acids. From 1.5 grams up to 3.0 grams per day orally);

The Di Bella's Method: Use of Melatonin since 1974 - together with others chemical compounds - in several Oncological Pathologies:

- A retrospective observational clinical study of triple negative breast cancer cases treated with Di Bella Method: A preliminary data;

- The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer;

- Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast;

- Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report;

- The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer;

- Complete objective response to biological therapy of plurifocal breast carcinoma;

- A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness;